共 42 条
- [1] Arrow KJ(1963)Uncertainty and the welfare economics of medical care The American Economic Review 53 941-973
- [2] Blume-Kohout ME(2013)Market size and innovation: Effects of medicare part D on pharmaceutical research and development Journal of Public Economics 97 327-336
- [3] Sood N(2011)Medicare part D and changes in prescription drug use and cost burden: National estimates for the medicare population, 2000 to 2007 Medical Care 49 834-841
- [4] Briesacher BA(1988)Sample design, sampling variance, and estimation procedure for the national abulatory medical care survey Vital and Health Statistics. Series 2. Data Evaluation and Methods Research 108 1-39
- [5] Bryant EE(1998)Contracting for health services when patient demand does not reflect quality Journal of Health Economics 17 1-19
- [6] Shimizu I(1987)A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation Journal of Chronic Diseases 40 373-383
- [7] Chalkley M(2010)The effect of medicare part D on pharmaceutical prices and utilization American Economic Review 100 590-607
- [8] Malcomson JM(2011)The medium-term impact of medicare part D on pharmaceutical prices American Economic Review 101 387-392
- [9] Charlson ME(1986)Provider behavior under prospective reimbursement Journal of Health Economics 5 129-151
- [10] Duggan M(2011)Medicare Part D and the financial protection of the elderly American Economic Journal: Economic Policy 3 77-102